Skip to main content

Test Price

2,800 AED

โœ… Home Collection Available

CACNA1F Gene Cone-Rod Dystrophy, X-Linked Type 3 Genetic Test in UAE | 2,800 AED | DNA Labs UAE

Executive Summary & Core Metrics

  • Test Name: CACNA1F Gene Sequencing (Cone-Rod Dystrophy, X-Linked Type 3)
  • Price: 2,800 AED
  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Peripheral Whole Blood (VIP Home Collection Available)
  • Methodology: Next Generation Sequencing (NGS) โ€“ Full Gene Coverage
  • Diagnostic Accuracy: 99.9% Sensitivity validated by ISO 9001:2015
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731

Test Overview & Methodology

The CACNA1F gene test utilizes Next Generation Sequencing (NGS) to detect pathogenic mutations responsible for X-linked cone-rod dystrophy. Performed under ISO 9001:2015 certification and the DNA Labs UAE DHA regulatory framework, the assay ensures comprehensive coverage of all coding exons and splice sites for definitive molecular diagnosis.

Feature Our Test (NGS) Standard Sanger Sequencing
Precision Full gene coverage, 99.9% sensitivity Limited to pre-known mutations, ~95% sensitivity
Methodology Next Generation Sequencing (NGS) โ€“ simultaneous analysis of all exons Targeted exon amplification by PCR
Turnaround Time 3 to 4 Weeks 2 to 3 Weeks (faster but less comprehensive)

Physician Insight & Safety Protocols

"Identifying a pathogenic variant in the CACNA1F gene is a critical step in confirming the diagnosis of X-linked cone-rod dystrophy. It empowers families with accurate recurrence risk assessment and enables eligibility for emerging gene therapy clinical trials. A comprehensive ophthalmological evaluation must accompany genetic results for a complete clinical picture."

โ€” Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

โš ๏ธ Medical Advisory: Do Not Alter Prescribed Therapies

Patients are strongly advised against discontinuing or modifying prescribed ophthalmic medications or vitamin regimens without direct consultation with their treating ophthalmologist or genetic counselor.

Exclusion Criteria & Emergency Red Flags

  • Active ocular infection or acute intraocular inflammation.
  • Inability to provide a peripheral blood sample (e.g., severe coagulopathy, lack of venous access).
  • Minors under 18 years without legal guardian consent (per UAE Federal Law).
  • ๐Ÿ†˜ ER Red Flags: Sudden vision loss, severe eye pain, new flashes/floaters, or curtainโ€‘like shadow in vision โ€“ seek emergency eye care immediately.

Patient FAQ & Clinical Guidance

1. What is the CACNA1F gene cone-rod dystrophy test and why is it performed?

The CACNA1F gene test detects inherited mutations responsible for X-linked cone-rod dystrophy (CORDX3), a condition causing progressive deterioration of central and peripheral vision, often beginning in childhood. Genetic confirmation enables precise family counseling, carrier detection, and eligibility assessment for emerging experimental therapies.

2. How accurate is the NGS testing method for this specific genetic analysis?

Our NGS-based assay delivers 99.9% sensitivity for detecting pathogenic single-nucleotide variants and small insertions/deletions within the CACNA1F gene. Validation is performed against ISO 9001:2015 standards, ensuring robust and reproducible clinical results for informed medical decision-making.

3. Does insurance cover the 2,800 AED cost in the UAE, and how can I arrange a home collection?

Yes, we facilitate direct billing with major UAE health insurance providers upon pre-approval. Contact us via WhatsApp at +971 54 548 8731 to verify your coverage and schedule a VIP mobile phlebotomy appointment. Our temperature-controlled cold-chain home collection service operates daily from 8 AM to 11 PM, ensuring sample integrity from your doorstep to our ISO-accredited laboratory.

UAE Regulatory & Data Privacy Adherence

Regulatory & Data Privacy Compliance Framework

DNA Labs UAE strictly adheres to the following UAE federal legislations governing genetic testing, medical liability, and patient data protection:

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ€“ Ensuring confidential handling of genetic and biometric data.
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ€“ Safeguarding electronic health records and telemedicine interactions.
  • Federal Decree-Law No. 4 of 2016 on Medical Liability โ€“ Governing clinical practice standards and patient safety protocols during sample collection and result disclosure.
  • DHA Facility License Number: 1143 | ISO 9001:2015 Certificate: INT/EGQ/2509DA/3139

Clinical & Logistical Metadata

Test Name CACNA1F Gene Sequencing (Cone-Rod Dystrophy, X-Linked Type 3)
Price (AED) 2,800 AED
Turnaround Time 3 to 4 Weeks (21 โ€“ 28 Business Days)
Sample Type / Matrix Peripheral Whole Blood (EDTA Tube). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available daily from 8 AM to 11 PM.
Methodology Used Next Generation Sequencing (NGS) โ€“ Full Exon Coverage with CNV Detection
ICD-10-CM Code H35.54 (Cone-Rod Dystrophy)
LOINC Code 94233-3 (CACNA1F gene mutation analysis)
DHA License & Address DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians